KMT2A and acute kidney injury: To investigate the role of MLL1/WDR5 in cisplatin-induced AKI, mice were treated with MM102, an inhibitor of the MLL1/WDR5 complex [21], or vehicle 2 h before cisplatin administration (20 mg/kg, intraperitoneally injection).